SCHEMBL364147

SCHEMBL364147

NC(=O)NN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29575364 0.97
SCHEMBL29662832 0.97
Methane SCHEMBL22750371 0.97
Ethane SCHEMBL8670767 0.94
Cyclohexane SCHEMBL7111797 0.91 ALDH1A1 (0.43)
SCHEMBL4203470 0.88 LMNA (0.33)
Butane SCHEMBL28038675 0.86 KDM4E (0.36)
Ethyl Chloride SCHEMBL4751020 0.84
SCHEMBL10933886 0.84 LMNA (0.33)
SCHEMBL27812723 0.80 KDM4E (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5308 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746898-A2 IDENTIFICATION OF SEQUENCE VARIANTS OF THE ERVMER34-1 SEQUENCE FAMILY AND USE IN ANTI-CANCER THERAPIES The United States of America, as represented by the Secretary, Department of Health and Human Services (US) 2026-05-27 EP claimed
US-20260137794-A1 LIGAND-DRUG CONJUGATE AND USE THEREOF SYSTIMMUNE INC (US) 2026-05-21 US claimed
WO-2026102563-A1 DISUBSTITUTED PYRIMIDOPYRROLE ANALOG AND USE THEREOF 深圳湾实验室坪山生物医药研发转化中心 2026-05-21 WO claimed
US-12630593-B2 Method of killing leukemia cells by administration of recombinant'Y3 proteins UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2026-05-19 US claimed
CN-122067631-A Method and system for analyzing enzymatic synthesis mechanism of N-nitrosourea compound 山东中医药大学 2026-05-19 CN claimed
US-20260116861-A1 ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) 2026-04-30 US claimed
EP-4727979-A2 COMPOSITIONS AND METHODS FOR TARGETING EXTRACELLULAR DNA Caris Science, Inc. (US) 2026-04-22 EP claimed
EP-4729063-A2 TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES BPGbio, Inc. (US) 2026-04-22 EP claimed
US-20260090990-A1 DRUG DELIVERY SYSTEM LIPOGEMS INT S P A (IT) 2026-04-02 US claimed
EP-4687980-A1 COMPOSITIONS AND METHODS FOR TREATING SOLID TUMORS WITH ANTI-BTLA AS COMBINATION THERAPY Shanghai Junshi Biosciences Co., Ltd. (CN) 2026-02-11 EP claimed
WO-2006050124-A2 EVALUATION OF THE TOXICITY OF PHARMACEUTICAL AGENTS NOVARTIS AG (CH) 2006-05-11 WO claimed
WO-2005120577-A2 DERIVATIVES OF CHEMOTHERAPEUTIC AGENTS WITH A FORMALDEHYDE RELEASING MOEITY RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2005-12-22 WO claimed
US-20050176696-A1 Synergistic anit-cancer compounds REGENTS OF THE UNIVERSITY OF ARIZONA (US) 2005-08-11 US claimed
WO-2005058307-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING PLATINUM COMPLEXES WITH SECONDARY XANTHATES AND THERAPEUTIC USES THEREOF DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFESTIFTUNG DES ÖFFENTLICHEN RECHTS (DE) 2005-06-30 WO claimed
EP-1541142-A1 Pharmaceutical compositions containing platinum complexes with secondary xanthates and therapeutic uses thereof Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) 2005-06-15 EP claimed
US-20050090659-A1 Phospholepid derivatives of nucleosides as antitumaorl medicaments GANYMED 256 VERMOEGENSVERWALTUNGS GMBH (DE) 2005-04-28 US claimed
EP-1107751-B1 MEDICAMENT CONTAINING PLATINUM COMPLEX COMPOUNDS AND THE USE THEREOF DEUTSCHES KREBSFORSCH (DE) 2003-06-04 EP claimed
EP-0128018-B1 MOLECULAR GENETIC PROBE, AND METHOD OF FORMING SAME, ASSAY TECHNIQUE AND KIT USING SAID MOLECULAR GENETIC PROBE Orgenics Ltd. (IL) 1992-07-15 EP claimed
EP-0089693-B1 STEROID ESTERS OF N-(2-HALOGEN-ETHYL)-N-NITROSO-CARBAMOYL AMINO ACIDS AND THEIR PEPTIDES, AND PROCESS FOR THEIR PREPARATION Stiftung Deutsches Krebsforschungszentrum (DE) 1985-11-06 EP claimed
US-4377687-A ANTITUMOR STIFTUNG DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 1983-03-22 US claimed